The founders of Entrocoat™  by Zognition, LLC have over 60 years of experience in the healthcare industry. Combining their respective expertise in medicine, pharmaceuticals, probiotics, and supplements to offer the best probiotics for health. There continues to be expanding evidence of the role that symbiotic bacterium in our gut plays a pivotal role in inflammation and disease. Entrocoat™ is dedicated to developing the industry’s leading probiotic supplements to improve health by restoring the homeostatic balance of the gut microbiome. Studies in dry eye, blepharitis, and other disease with effects on the eye, such as rosacea, have also proven the benefits of probiotics.

Entrocoat™ probiotics is releasing our first product, Cydexa to aid and benefit people suffering with dry eye, blepharitis, and related eye conditions. Cydexa is the perfect first release in our “best probiotics for health” product line. Developed by a Board-Certified Ophthalmologist, Cydexa’s proprietary formula is a blend of probiotics including Lactobacillus reuteri which has been studied and found to produce positive results in the relief of dry eye symptoms.

Cydexa offers auto encapsulating prebiotics to produce inclusion bodies for efficient delivery of our proprietary probiotics once ingestion starts. This auto encapsulation process protects against external stressors and act as a prebiotic agent to envelop the probiotics when it becomes moist during ingestion.

Entrocoat™ is a US company with all our probiotic strains manufactured, capsulated and packaged in the USA in cGMP and FDA certified facilities to offer the best probiotics for health.

With the growing body of evidence for many years that the symbiotic bacteria in our gut or the microbiota ecology plays a pivotal role in inflammation and disease pathogenesis. Transplantation of gut bacteria is widely used to treat intractable diarrhea caused by Clostridium difficile and is also an effective therapy for Crohn’s disease. Dry eye, blepharitis, and other disease with large effects on the eye such as rosacea are due to an underlying inflammatory process, like Crohn’s disease. Probiotic supplements can improve ocular health by restoring the homeostatic balance of the gut microbiome. The founders of Entrocoat™ bring over 60 years of healthcare experience and expertise to the company. They also bring a powerful vision to offer customers the best probiotic supplements for health on the market.

A distinguished chemist, Dr. Pham is an innovative entrepreneur and practicing ophthalmologist in Houston. He began his academic journey by graduating summa cum laude with a degree in chemistry, following which he earned his medical degree from the prestigious Washington University School of Medicine in St. Louis. Dr. Pham completed his ophthalmology residency at the renowned Doheny Eye Institute in Los Angeles, where he showcased his innovative spirit by co-developing the first online visual field system for glaucoma and macular degeneration. This trailblazing effort in remote patient care set the groundwork for establishing RemoniHealth, a company dedicated to managing complex diseases using enterprise-scale telemedicine technology.

In addition to his accomplishments in medicine and technology, Dr. Pham has made consequential strides in the field of natural health solutions. He patented an innovative system using okra polysaccharide complexes, known as Zokrex, as a natural alternative for addressing inflammation. The Zokrex platform is the only clinically proven alternative to tea tree oil for treating ocular Demodex without the stinging and discomfort of tea tree oil. This invention underlines his commitment to integrating natural science with medical applications. He is the CEO and Founder of Okra LLC, a company that stands at the forefront of incorporating the Zokrex platform in its line of Zocular products. His leadership in launching this product line demonstrates his ability to bridge the gap between scientific innovation and market needs, making him a dynamic force in the health and technology industry.

Mr. Choate has 30+ years of experience in the domestic and international medical device and pharmaceutical industries. He began his career at Alcon Laboratories and advanced in positions at Alcon, then at Medtronic Neuro. In 1999, he spearheaded the medical division at Microvision where more than $80M was raised in DOD funding to develop new medical devices for field use by the military/TATRIC. In 2003, he founded Advanced Pharma International that acquired/licensed OTC/pharmaceuticals as well as developing/marketing probiotics for adults and children for use in NA, Asia and EU.  In 2013, he co-founded BlephEx and is co-inventor of two Patented ophthalmic devices to treat blepharitis that are marketed globally.

John has also raised more than $1B in funding during his career and holds multiple US/global Patents. John provides consulting to Chinese pharma and medical device companies and is a board member for several companies in various sectors from health care to industrial nanotechnology as well as a consultant to several PE firms specializing in the medical device and pharmaceutical markets in the US and Asia.

Dr. Pham and John Choate formed Zognition, LLC by combining their six decades of expertise in medicine, pharmaceuticals, probiotics and supplements to release their new line of Entrocoat™ probiotics. The first, Cydexa, aids people suffering with dry eye, blepharitis, and related eye conditions. The company is investing heavily in developing new probiotics to not only treat eye conditions, but to offer the best probiotic supplements for health for the overall health of its customers.